If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

Research in the Crispino laboratory is focused on investigating the regulatory mechanisms governing normal and malignant blood cell development, with an emphasis on understanding the growth of erythroid cells (red blood cells) and megakaryocytes (platelet-producing cells). In addition, the group has a major interest in learning how changes in normal essential regulatory molecules lead to human blood diseases, including acute leukemias and myeloproliferative neoplasms (MPNs). The lab seeks to make seminal basic science discoveries while simultaneously translating these discoveries in ways that will benefit patients with hematologic malignancies.

Education/Academic qualification

PhD, MIT

… → 1996

Research interests

  • Blood Cancer (leukemia and lymphomas)
  • Gene Regulation
  • Molecular Biology
  • Blood and Bleeding Disorders (anemia, clotting, etc.)

Fingerprint Dive into the research topics where John D Crispino is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 25 Similar Profiles
Megakaryocytes Medicine & Life Sciences
Leukemia, Megakaryoblastic, Acute Medicine & Life Sciences
Down Syndrome Medicine & Life Sciences
Mutation Medicine & Life Sciences
Leukemia Medicine & Life Sciences
Primary Myelofibrosis Medicine & Life Sciences
Hematopoiesis Medicine & Life Sciences
Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2006 2024

Myeloid Progenitor Cells
Acute Myeloid Leukemia
Myeloid Cells
Down Syndrome
Genes
Chromatin Assembly and Disassembly
Leukemia
Stem Cells
Genes
Down Syndrome
Neoplasms
Essential Thrombocythemia
Polycythemia Vera
Primary Myelofibrosis
Clustered Regularly Interspaced Short Palindromic Repeats
Neoplasms
Medicine
Research
Population

Research Output 1991 2019

AKT activation is a feature of CALR mutant myeloproliferative neoplasms

Fu, C., Wen, Q., Marinaccio, C., Ling, T., Chen, W., Bulic, M., Lasho, T., Tefferi, A., Crispino, J. D. & Xu, K., Jan 1 2019, In : Leukemia. 33, 1, p. 271-274 4 p.

Research output: Contribution to journalArticle

Neoplasms
4 Citations (Scopus)

An activating mutation of the NSD2 histone methyltransferase drives oncogenic reprogramming in acute lymphocytic leukemia

Swaroop, A., Oyer, J. A., Will, C. M., Huang, X., Yu, W., Troche, C., Bulic, M., Durham, B. H., Wen, Q., Crispino, J. D., MacKerell, A. D., Bennett, R. L., Kelleher, N. L. & Licht, J. D., Jan 31 2019, In : Oncogene. 38, 5, p. 671-686 16 p.

Research output: Contribution to journalArticle

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Mutation
Histones
Methylation
Lysine

GATA-1: A potential novel biomarker for the differentiation of essential thrombocythemia and myelofibrosis

Lally, J., Boasman, K., Brown, L., Martinelli, V., Cappuccio, I., Sovani, V., Marinaccio, C., Crispino, J. D., Graham, C. & Rinaldi, C., Jun 1 2019, In : Journal of Thrombosis and Haemostasis. 17, 6, p. 896-900 5 p.

Research output: Contribution to journalArticle

Essential Thrombocythemia
Primary Myelofibrosis
Biomarkers
Megakaryocytes
Messenger RNA
1 Citation (Scopus)

Regulation of MLL/COMPASS stability through its proteolytic cleavage by taspase1 as a possible approach for clinical therapy of leukemia

Zhao, Z., Wang, L., Volk, A. G., Birch, N. W., Stoltz, K. L., Bartom, E. T., Marshall, S. A., Rendleman, E. J., Nestler, C. M., Shilati, J., Schiltz, G. E., Crispino, J. D. & Shilatifard, A., Jan 1 2019, In : Genes and Development. 33, 1-2, p. 61-74 14 p.

Research output: Contribution to journalArticle

Aspartate Ammonia-Lyase
Threonine
Leukemia
Casein Kinase II
Therapeutics
8 Citations (Scopus)

The thrombopoietin/MPL axis is activated in the gata1low mouse model of myelofibrosis and is associated with a defective RPS14 signature

Zingariello, M., Sancillo, L., Martelli, F., Ciaffoni, F., Marra, M., Varricchio, L., Rana, R. A., Zhao, C., Crispino, J. D. & Migliaccio, A. R., Jan 1 2019, In : Blood cancer journal. 7, 6, e572.

Research output: Contribution to journalArticle

Thrombopoietin
Primary Myelofibrosis
Megakaryocytes
Messenger RNA
Polyribosomes